Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Cardiovascular Science researchers awarded grant to develop new treatments for autoimmune conditions The researchers will undertake the project to improve the outcome for patients diagnosed with autoimmune conditions, such as rheumatoid arthritis or psoriasis.
News Birmingham cardiovascular scientists appointed editor and deputy editor of international journals
29 June 2021 Launch of the national Congenital Heart Disease Priority Setting Partnership Today, 29 June 2021, sees the launch of the UK's first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).
15 June 2021 Professor's success story used to mark BHF's 60th birthday celebrations Professor Paulus Kirchhof's success story of the the EAST-AFNET 4 clinical trial has been featured in the BHF's 60th birthday celebrations.
06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.
23 April 2021 Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
14 April 2021 New research to explore and treat thrombo-inflammation in diseases attacking red blood cells Dr Julie Rayes was awarded a reputable Fellowship to study, test and repurpose drugs to limit thrombo-inflammation caused by infection or congenital disorders.
31 March 2021 Machine learning and AI for early detection of atrial fibrillation and stroke A new EU-funded collaborative research project will develop the first integrative digital platform for diagnosing atrial cardiomyopathy.
24 March 2021 Experts publish key recommendations for innovation in atrial fibrillation Experts have come together to discuss the latest innovations in atrial fibrillation research and publish a set of agreed clinical and research recommendations.
15 March 2021 Karger: Spotlight on Professor Dipak Kotecha, Associate Editor Article about Professor Dipak Kotecha, Associate Editor of Karger and Professor of Cardiology at the Institute of Cardiovascular Sciences, where he talks about himself and his research.
01 February 2021 Latest trial led by Birmingham Professor shows digoxin is effective in treating atrial fibrillation A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when treating patients with permanent atrial fibrillation.
27 January 2021 Sir Henry Wellcome Fellowship awarded to Dr Christopher O'Shea Dr Christopher O'Shea from at the Institute of Cardiovascular Sciences has been awarded a prestigious Postdoctoral Fellowship from the Wellcome Trust.
13 January 2021 Hunterian Professorship awarded to Birmingham Clinician Scientist Mr Nigel Drury, Clinician Scientist in Paediatric Cardiac Surgery at the University of Birmingham, has received the prestigious Hunterian Professorship.